Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 1 1

Status

Completed 24Recruiting 18Terminated 11Active not recruiting 8Unknown 6Withdrawn 5Not yet recruiting 2Temporarily not available 1No longer available 1Enrolling by invitation 1

Sponsor Class

OTHER 6

Study Type

Interventional 4Observational 2

Sponsor

Cancer Type

Genitourinary 6

Conditions

Breast Neoplasms 1841Neoplasms 1230Colorectal Neoplasms 1046Carcinoma, Non-Small-Cell Lung 996Stomach Neoplasms 787Carcinoma, Hepatocellular 780Lung Neoplasms 756Prostatic Neoplasms 682Pancreatic Neoplasms 567Rectal Neoplasms 444Colonic Neoplasms 401Neoplasm Metastasis 400Ovarian Neoplasms 399Uterine Cervical Neoplasms 395Recurrence 380Leukemia, Myeloid, Acute 367Esophageal Neoplasms 352Multiple Myeloma 340Lymphoma 330Head and Neck Neoplasms 326Melanoma 306Precursor Cell Lymphoblastic Leukemia-Lymphoma 288Brain Neoplasms 263Urinary Bladder Neoplasms 249Nasopharyngeal Carcinoma 221Liver Neoplasms 221Leukemia 217Lymphoma, Large B-Cell, Diffuse 213Polycystic Ovary Syndrome 206Squamous Cell Carcinoma of Head and Neck 200

Interventions

Abiraterone Acetate 2enzalutamide 1cabazitaxel 1abiraterone 1Prednisone 1Photons 1Exome Sequencing 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Unknown × Prostatic Neoplasms, Castration-Resistant × Clear all
NCT05902247 2023-06-13

225AcPSMAI&T

Erasmus Medical Center

Phase 1 Unknown
30 enrolled
Genitourinary

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT04141709 2023-02-08

OLI-CR-P

Technische Universität Dresden

Phase NA Unknown
66 enrolled
Genitourinary

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT04833517 2022-12-08

Prospective REgistry of Targeted RadionucLide TherapY in Patients With mCRPC (REALITY Study)

Universität des Saarlandes

Unknown
500 enrolled
Genitourinary

Prostatic Neoplasms, Castration-Resistant

NCT05156450 2021-12-14

TQB3616 Capsules Combined With Abiraterone Acetate Plus Prednisone in Metastatic Castration-Resistant Prostate Cancer

West China Hospital

Phase 2 Unknown
30 enrolled
Genitourinary

Prostatic Neoplasms, Castration-Resistant

NCT04126915 2019-11-05

PTtWES

Changhai Hospital

Unknown
200 enrolled
Genitourinary

Prostatic Neoplasms, Castration-Resistant

NCT02254785 2017-12-06

Cabazitaxel vs Abiraterone or Enzalutamide in Patients With Poor Prognosis Metastatic Castration-resistant Prostate Cancer

British Columbia Cancer Agency

Phase 2 Unknown
120 enrolled
Genitourinary

Prostatic Neoplasms, Castration-Resistant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡